Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rhonda Griffin"'
Autor:
Vera Bril, Andrzej Szczudlik, Antanas Vaitkus, Csilla Rozsa, Anna Kostera-Pruszczyk, Petr Hon, Josef Bednarik, Michaela Tyblova, Wolfgang Köhler, Toomas Toomsoo, Richard J. Nowak, Tahseen Mozaffar, Miriam L. Freimer, Michael W. Nicolle, Tim Magnus, Michael T. Pulley, Michael Rivner, Mazen M. Dimachkie, B. Jane Distad, Robert M. Pascuzzi, Donna Babiar, Jiang Lin, Montse Querolt Coll, Rhonda Griffin, Elsa Mondou
Publikováno v:
Neurology, vol 100, iss 7
Background and ObjectivesMyasthenia gravis (MG) is an autoimmune disease characterized by dysfunction at the neuromuscular junction. Treatment frequently includes corticosteroids (CSs) and IV immunoglobulin (IVIG). This study was conducted to determi
Autor:
Josée Michaud, Wei Liang, Jeffrey Price, Martin Kankam, Rhonda Griffin, Bradley Vince, Ana Sanz, Mariona Bassas Llorens, David Vilardell
Publikováno v:
Advances in Therapy
Background Analytical data suggesting that immunoglobulin given intramuscularly (IGIM) may have reduced protection against hepatitis A virus (HAV) infection led to an update in the recommended IGIM dose (0.2 ml/kg). Methods This prospective, open-lab
Autor:
Manuel Santamaria, Olaf Neth, Jo A. Douglass, Gergely Krivan, Robin Kobbe, Ewa Bernatowska, Sofia Grigoriadou, Claire Bethune, Anita Chandra, Gerd Horneff, Michael Borte, Anja Sonnenschein, Pavlina Kralickova, Silvia Sánchez Ramón, Daman Langguth, Luis Ignacio Gonzalez-Granado, Laia Alsina, Montse Querolt, Rhonda Griffin, Carrie Hames, Elsa Mondou, Jeffrey Price, Ana Sanz, Jiang Lin
[Purpose] The purpose of this phase 3 study was to evaluate the efficacy, pharmacokinetics (PK), and safety of Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%) in patients with primary immunodeficiency (PI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf11c351ac393c350c85d612e04bdd08
https://hdl.handle.net/10668/20596
https://hdl.handle.net/10668/20596
Autor:
Manuel Santamaria, Olaf Neth, Jo A. Douglass, Gergely Krivan, Robin Kobbe, Ewa Bernatowska, Sofia Grigoriadou, Claire Bethune, Anita Chandra, Gerd Horneff, Michael Borte, Anja Sonnenschein, Pavlina Kralickova, Silvia Sánchez Ramón, Daman D. Langguth, Luis Ignacio Gonzalez‑Granado, Laia Alsina, Montse Querolt, Rhonda Griffin, Carrie Hames, Elsa Mondou, Jeffrey Price, Ana Sanz, Jiang Lin
Publikováno v:
Journal of Clinical Immunology. 42:512-513
Autor:
Rodica Balasa, Jeannine M. Heckmann, Guntis Karelis, Sandra Camprubi, Elsa Mondou, Andres Villa, Tima Stuchevskaya, Junliang Chen, Michael W. Nicolle, Vera Bril, Jan De Bleecker, Crisandra Vilciu, Rhonda Griffin, Emmeline Lagrange, Philip Van Damme, Waleska Henriquez, Jaume Ayguasanosa, Beatriz Garcia
Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission. Exacerbations may involve increasing bulbar weakness and/or sudden respiratory failure, both of which can be critically disabling. Management of MG exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01420125ce8d110230d35fa1efc30a51
https://lirias.kuleuven.be/handle/123456789/664157
https://lirias.kuleuven.be/handle/123456789/664157
Publikováno v:
Journal of the neurological sciences. 406
Since the death of Chief Opechankanough >350 years ago, the myasthenia gravis (MG) community has gained extensive knowledge about MG and how to treat it. This review highlights key milestones in the history of treatment and discusses the current “g
Autor:
Jennifer Heimall, Gary I. Kleiner, Rhonda Griffin, Isaac Melamed, Junliang Chen, Joseph A. Church
Publikováno v:
Journal of Clinical Immunology. 36:600-609
This phase 4, multicenter, open-labeled, single-sequence, crossover study in pediatric patients (ages 2 to 16) with primary immunodeficiency disease (PID) evaluated the pharmacokinetics, safety, and tolerability for subcutaneously (SC) administered 1
Autor:
Henry L. Dorkin, James F. Chmiel, Junliang Chen, David P. Nichols, Scott H. Donaldson, Rhonda Griffin, Patrick A. Flume, Amit Gaggar
Publikováno v:
Journal of Cystic Fibrosis. 15:227-233
Inhaled alpha1-proteinase inhibitor (PI) is known to reduce neutrophil elastase burden in some patients with CF. This phase 2a study was designed to test inhaled Alpha-1 HC, a new aerosolized alpha1-PI formulation, in CF patients.We performed a rando
Publikováno v:
Transfusion. 58
Background Widespread vaccination against measles has resulted in decreasing measles antibody levels in human immune globulin (IG) products. As levels continue to decline, it needs to be determined whether the release specifications for measles antib
Autor:
Rhonda Griffin, Hubert Fornalik, Urs von Holzen, Leonard R. Henry, Ashley N. Hardy, Roderich E. Schwarz, Michael J. Minarich
Publikováno v:
American journal of surgery. 217(3)
Background Administrative data are widely used as determinants of surgical quality. We compared surgical complications identified in a structured surgical review to coding and billing data of over a 19-month period. Methods A retrospective review of